Nanobiotix SA
SWB:5NR
Nanobiotix SA
SWB:5NR
Price:
27.38
EUR
-1.44%
Market Cap:
€1.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Nanobiotix SA
SWB:5NR
|
FR |
|
Enensys Technologies SA
F:20U
|
FR |
|
Iress Ltd
F:BRF
|
AU |
|
Olam Group Ltd
F:K25
|
SG |
|
Gecina SA
F:GI6A
|
FR |
|
Haverty Furniture Companies Inc
F:25F0
|
US |
|
Loomis AB
F:K900
|
SE |
|
US Global Investors Inc
NASDAQ:GROW
|
US |
|
Omni Bridgeway Ltd
ASX:OBL
|
AU |
|
L
|
Lindsay Corp
SWB:LMF
|
US |
|
A
|
Automatic Data Processing Inc
DUS:ADP
|
US |
|
V
|
VirNect Co Ltd
KOSDAQ:438700
|
KR |
|
B
|
BXP Inc
F:BO9
|
US |
|
F
|
Five Below Inc
SWB:6F1
|
US |
|
Tokyo Ohka Kogyo Co Ltd
TSE:4186
|
JP |
|
Nomura Research Institute Ltd
F:NR7
|
JP |
|
L
|
Logitech international SA
XHAM:LTEC
|
CH |
|
Carlo Gavazzi Holding AG
SIX:GAV
|
CH |
|
P
|
Procter & Gamble Co
DUS:PRG
|
US |
|
Barton Gold Holdings Ltd
F:BGD3
|
AU |
|
Toho Co Ltd (Tokyo)
F:TOH
|
JP |
|
H
|
HNI Corp
F:HO9
|
US |
Intrinsic Value
Not Available for 5NR
There is not enough data to reliably calculate the intrinsic value for Nanobiotix SA.
Do our valuations actually work? See backtest results .
Alternatives to 5NR
Fundamental Analysis
What Nanobiotix Does
Nanobiotix is a French biotechnology company focused on cancer treatment. Its main product is a nanoparticle-based therapy that is designed to be injected into a tumor and activated by radiotherapy, with the goal of making radiation kill more cancer cells while limiting damage to healthy tissue. The company is still building this into an approved medical business rather than selling a broad range of medicines.
- Headquarters
- France FR
- Employees
- 100
- IPO date
- Oct 29, 2012
Financials
Efficiency
Earnings Waterfall
Nanobiotix SA
Nanobiotix SA
